162 related articles for article (PubMed ID: 15701268)
61. Endoluminal high dose rate brachytherapy in the treatment of primary and recurrent bronchogenic tree malignancies.
Fortunato M; Feijó S; Almeida T; Mendonça V; Aguiar M; Jorge M; Monteiro Grillo I
Rev Port Pneumol; 2009; 15(2):151-64. PubMed ID: 19280066
[TBL] [Abstract][Full Text] [Related]
62. [Use of intraluminal brachytherapy for treatment of patients with non-small cell lung cancer in cases of local failure after teleradiotherapy].
Makarewicz R; Kuźmińska A
Pneumonol Alergol Pol; 1996; 64(7-8):444-9. PubMed ID: 8983445
[TBL] [Abstract][Full Text] [Related]
63. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
64. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
65. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
66. [Treatment of obstructive bronchial cancers with high dose, endobronchial curietherapy. Technical aspects and clinical results].
Taulelle M; De Faucal H; Bénézet O; Yacono M; Chauvet B; Vincent P; Bucciarelli B; Brewer Y; Félix-Faure C; Reboul F
Rev Mal Respir; 1993; 10(4):347-51. PubMed ID: 7694332
[TBL] [Abstract][Full Text] [Related]
67. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
[TBL] [Abstract][Full Text] [Related]
68. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.
Kelly JF; Delclos ME; Morice RC; Huaringa A; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):697-702. PubMed ID: 11020566
[TBL] [Abstract][Full Text] [Related]
69. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
70. Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer.
Chan MD; Dupuy DE; Mayo-Smith WW; Ng T; DiPetrillo TA
Brachytherapy; 2011; 10(3):253-9. PubMed ID: 20739227
[TBL] [Abstract][Full Text] [Related]
71. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
72. Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life.
Ost DE; Ernst A; Grosu HB; Lei X; Diaz-Mendoza J; Slade M; Gildea TR; Machuzak MS; Jimenez CA; Toth J; Kovitz KL; Ray C; Greenhill S; Casal RF; Almeida FA; Wahidi MM; Eapen GA; Feller-Kopman D; Morice RC; Benzaquen S; Tremblay A; Simoff M;
Chest; 2015 May; 147(5):1282-1298. PubMed ID: 25358019
[TBL] [Abstract][Full Text] [Related]
73. Palliative management of malignant airway obstruction.
Morris CD; Budde JM; Godette KD; Kerwin TL; Miller JI
Ann Thorac Surg; 2002 Dec; 74(6):1928-32; discussion 1932-3. PubMed ID: 12643375
[TBL] [Abstract][Full Text] [Related]
74. Therapeutic bronchoscopy in lung cancer. Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy.
Lee P; Kupeli E; Mehta AC
Clin Chest Med; 2002 Mar; 23(1):241-56. PubMed ID: 11901914
[TBL] [Abstract][Full Text] [Related]
75. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
76. [Treatment of malignant central airways obstruction by rigid bronchoscopy].
Huret B; Perez T; Dhalluin X; Dewavrin F; Ramon PP; Fournier C
Rev Mal Respir; 2015 May; 32(5):477-84. PubMed ID: 26072007
[TBL] [Abstract][Full Text] [Related]
77. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
78. Outcomes of airway stenting for advanced lung cancer with central airway obstruction.
Saji H; Furukawa K; Tsutsui H; Tsuboi M; Ichinose S; Usuda J; Ohira T; Ikeda N
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):425-8. PubMed ID: 20656802
[TBL] [Abstract][Full Text] [Related]
79. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
80. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
